NeuroPhet Expands MS Detection AI Partnership with VHIR

Leveraging Specialized MRI Datasets for MS Lesion Detection

NeuroPhet, a South Korean artificial intelligence (AI) medical diagnostics company, has expanded its collaboration with Spain’s Vall d’Hebron Institut de Recerca (VHIR) to develop an AI algorithm for detecting multiple sclerosis (MS) lesions using magnetic resonance imaging (MRI) data. The partnership, announced on May 26, 2026, focuses on refining the company’s NeuroPhet AQUA MS software, … Read more

Mono infection associated with threefold higher multiple sclerosis risk

Having the disease infectious mononucleosis, often called mono, caused by the Epstein-Barr virus is associated with an increased risk of developing multiple sclerosis (MS), according to a study published on April 1, 2026, in Neurology® Open Access, an official journal of the American Academy of Neurology. The Epstein-Barr virus is a herpes virus that is … Read more

DNA damage in gray matter neurons linked to MS progression

For decades, multiple sclerosis research has focused on myelin, the insulation around the brain’s wiring. Scientists paid less attention to another loss that was happening in parallel: neurons in the cortex, the seat of higher thinking and cognition, were quietly dying. A team led by UC San Francisco, University of Cambridge, and Cedars-Sinai Medical Center … Read more

Gut immune responses found to trigger brain inflammation in MS

Multiple sclerosis (MS) is a debilitating neurological disorder caused by malfunctioning immune responses that target the brain and spinal cord of the central nervous system (CNS). What makes our body turn against itself? Failure of the immune system to distinguish ‘self’ from ‘non-self’ entities leads to excessive autoimmune responses against self-proteins like myelin, which forms … Read more

Multiple sclerosis prevalence in England doubles due to better diagnosis

Multiple sclerosis (MS) has more than doubled in recorded prevalence in England from 2000 to 2020, increasing by 6% per year, largely due to improved diagnosis and longer life expectancy, finds a new study by University College London (UCL) and Imperial College London researchers. The team found that survival of people with MS improved significantly … Read more

Georgia Woman Went for Her Annual Eye Exam. Then She Got a ‘Shock’ Multiple Sclerosis Diagnosis

NEED TO KNOW Andrea Medford was diagnosed with multiple sclerosis after visiting the eye doctor for blurry vision in one eye Dr. Rebecca Briggs Garnier identified optic neuritis during a vision test and sent Medford to the emergency room Routine eye exams can detect over 200 diseases, highlighting their importance beyond just checking vision health … Read more

Gene mutation that aids high-altitude survival could repair myelin sheath damage

A genetic mutation that helps animals like yaks and Tibetan antelopes survive at high altitudes may hold the key to repairing nerve damage in conditions such as cerebral paralysis and multiple sclerosis (MS). The finding, publishing March 13 in the Cell Press journal Neuron, reveals a naturally existing pathway that promotes regeneration after nerve damage and could open new doors for treating diseases like MS by leveraging molecules that are already present in the human body.  … Read more

Identifying common genetic markers for multiple sclerosis

A new study published in Neurology and led by Queen Mary University of London has revealed that people of South Asian, African , and European ancestry share many of the same genetic risk factors for multiple sclerosis (MS).  This new study is one of the most ancestrally diverse genetic analyses of MS conducted in the UK. MS affects around 150,000 people in the UK and more than two million people … Read more

Host control of persistent Epstein–Barr virus infection

Institute of Human Genetics, University of Bonn, School of Medicine and University Hospital Bonn, Bonn, Germany Axel Schmidt, T. Madhusankha Alawathurage, Friederike S. David, Leonard Frach, Sylvia Richter, Merle Schaefer, Carina M. Mathey, Sabrina K. Henne, Andreas J. Forstner, Markus M. Nöthen, Eva C. Beins & Kerstin U. Ludwig Department of Psychiatry and Psychotherapy, University of Marburg, Marburg, Germany Friederike S. David Department of Genome Informatics, Graduate … Read more

Can GLP-1 drugs slow neurodegeneration? New review finds promising signals but limited clinical proof

Emerging evidence suggests widely used metabolic drugs could influence brain aging pathways, yet large clinical trials are still needed to confirm whether they truly alter the course of neurodegenerative disease. Study: The promise of GLP-1 receptor agonists for neurodegenerative diseases. Image Credit: Antonio Marca / Shutterstock In a recent review published in the Journal of Clinical … Read more